Search

Your search keyword '"HAMPEL, G"' showing total 49 results

Search Constraints

Start Over You searched for: Author "HAMPEL, G" Remove constraint Author: "HAMPEL, G" Database MEDLINE Remove constraint Database: MEDLINE
49 results on '"HAMPEL, G"'

Search Results

1. Oculomics analysis in multiple sclerosis: Current ophthalmic clinical and imaging biomarkers.

2. An unusual origin of a papillary muscle of the right ventricle.

3. Process evaluation of a pilot evidence-based Polycystic Ovary Syndrome clinic in the Torres Strait.

5. Comparison of EPR response of alanine and Gd₂O₃-alanine dosimeters exposed to TRIGA Mainz reactor.

6. Quantitative bioimaging of p-boronophenylalanine in thin liver tissue sections as a tool for treatment planning in boron neutron capture therapy.

7. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.

8. Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy.

9. The alanine detector in BNCT dosimetry: dose response in thermal and epithermal neutron fields.

10. Confirmation of a realistic reactor model for BNCT dosimetry at the TRIGA Mainz.

11. Intercomparison of inductively coupled plasma mass spectrometry, quantitative neutron capture radiography, and prompt gamma activation analysis for the determination of boron in biological samples.

12. Dosimetric feasibility study for an extracorporeal BNCT application on liver metastases at the TRIGA Mainz.

13. Fast determination of impurities in metallurgical grade silicon for photovoltaics by instrumental neutron activation analysis.

14. Boron determination in liver tissue by combining quantitative neutron capture radiography (QNCR) and histological analysis for BNCT treatment planning at the TRIGA Mainz.

15. Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies.

16. Determination of boron concentration in blood and tissue samples from patients with liver metastases of colorectal carcinoma using Prompt Gamma Ray Activation Analysis (PGAA).

17. Biosorption of copper by wine-relevant lactobacilli.

18. Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz.

19. Forensic investigation of brick stones using instrumental neutron activation analysis (INAA), laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) and X-ray fluorescence analysis (XRF).

20. Reverse paintings on glass--a new approach for dating and localization.

21. Determination of the irradiation field at the research reactor TRIGA Mainz for BNCT.

22. Irradiation facility at the TRIGA Mainz for treatment of liver metastases.

23. Direct experimental verification of neutron acceleration by the material optical potential of solid 2H2.

24. Application of different TL detectors for the photon dosimetry in mixed radiation fields used for BNCT.

25. Different effects of cyclosporine and tacrolimus on the activation of mesangial metalloproteinases and their inhibitors.

26. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.

27. The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer.

28. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells.

29. [High-dose multimodal radiotherapy of confluent destructively growing aggregated keratoacanthoma. 2 case reports].

30. [Combined effect of Paclitaxel and ionizing radiation. Experimental data of in-vitro and in-vivo models].

33. Prostaglandin synthesis is increased in selenium supplemented human mesangial cells despite suppression of phospholipase A2-activity.

34. Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells.

35. Selenium-deficiency as contributing factor to anemia and thrombocytopenia in dialysis patients.

36. Myoglobinuric renal failure due to drug-induced rhabdomyolysis.

37. Adsorptive capacities of hemoperfusion devices in clinical use.

39. Experience with cellulose acetate-coated activated charcoal haemoperfusion in the treatment of severe hypnotic drug intoxication.

41. A schedule for combined intravenous and oral dosing with mexiletine.

42. Thrombin and histamine stimulate the phosphorylation of elongation factor 2 in human umbilical vein endothelial cells.

43. Experience with fixed-bred charcoal haemoperfusion in the treatment of severe drug intoxication.

44. Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells.

45. Value of emergency toxicological investigations in differential diagnosis of coma.

48. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].

Catalog

Books, media, physical & digital resources